Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000212213

Medchemexpress LLC Ethyl 4-(5-acrylamido-2-fluorophenyl)-7H-pyrrolo[2,3-d]pyrimidine-5-carboxylate | 1918238-72-8 | 99.8% | 354.34 g/mol | C18H15FN4O3 | 1 MG
SDP

Supplier:  Medchemexpress LLC HY1008491MG

Encompass_Preferred

JAK 3i is a selective, covalent inhibitor of Janus kinase 3 (JAK3) used as a research tool to study JAK/STAT signaling and immune biology. It potently inhibits JAK3 (IC50: 0.43 nM), forms a covalent bond with a cysteine residue in JAK3, and abolishes IL-2-driven T-cell proliferation in vivo.

  • Potent JAK3 inhibition (IC50: 0.43 nM).
  • Covalent mechanism targeting a cysteine residue in JAK3.
  • High selectivity versus related kinases.
  • Suitable for immunology and autoimmune disease research.
  • High purity for biochemical assays (HPLC 99.8%).
  • Available in small research quantities.

Catalog No. 50-002-12213


May include imposed supplier surcharges.
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.